Medicxi Ventures Management (Jersey) LTD Rapt Therapeutics, Inc. Transaction History
Medicxi Ventures Management (Jersey) LTD
- $455 Million
- Q4 2024
A detailed history of Medicxi Ventures Management (Jersey) LTD transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Medicxi Ventures Management (Jersey) LTD holds 22,352,000 shares of RAPT stock, worth $27.9 Million. This represents 7.76% of its overall portfolio holdings.
Number of Shares
22,352,000Holding current value
$27.9 Million% of portfolio
7.76%Shares
1 transactions
Others Institutions Holding RAPT
# of Institutions
100Shares Held
124MCall Options Held
246KPut Options Held
69.6K-
Tcg Crossover Management, LLC Palo Alto, CA13.1MShares$16.4 Million3.39% of portfolio
-
Orbimed Advisors LLC San Diego, CA13.1MShares$16.4 Million0.56% of portfolio
-
Foresite Capital Management Vi LLC Larkspur, CA12.5MShares$15.6 Million8.8% of portfolio
-
Rtw Investments, LP New York, NY11.8MShares$14.7 Million0.3% of portfolio
-
Bvf Inc San Francisco, CA9.24MShares$11.5 Million0.55% of portfolio
About RAPT Therapeutics, Inc.
- Ticker RAPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,656,600
- Market Cap $37.1M
- Description
- RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...